Luis Da Luz, Queen's University

Research

Bleeding Coagulopathy Haemorrhage Hypofibrinogenemia Inury Trauma

Latest funding

Prospective, multicentre, randomized, parallel-control, superiority study comparing administration of clotting factor concentrates with a standard massive hemorrhage protocol in severely bleeding trauma patients
CIHR · 2021 · Principal investigator
$1,021,276

All 1 grants and awards

Prospective, multicentre, randomized, parallel-control, superiority study comparing administration of clotting factor concentrates with a standard massive hemorrhage protocol in severely bleeding trauma patients

Principal investigatorCIHR2021Project Grant

Principal investigators: Callum, Jeannie L; Da Luz, Luis T

Keywords: Bleeding; Coagulopathy; Haemorrhage; Hypofibrinogenemia; Inury; Trauma

$1,021,276

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Mention their CIHR grant from 2021

Subject: Prospective PhD student: Bleeding Dear Professor Da Luz, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. Your research on bleeding connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "Prospective, multicentre, randomized, parallel-control, superiority study comparing administration of clotting factor concentrates with a standard massive hemorrhage protocol in severely bleeding trauma patients" (2021), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]